Company news
Knight Therapeutics, Inc. news in 2017
Knight Therapeutics, Inc.'s news releases, calls and decks from 2017, newest first.
Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid Drug Dependence
June 13, 2017
Research Reports Initiated on Healthcare Stocks Valeant Pharmaceuticals International, Merus Labs International, and Knight Therapeutics
March 9, 2017